Sheilaramjug Profile Banner
Sheila Profile
Sheila

@Sheilaramjug

Followers
298
Following
1K
Statuses
392

Wife, Mother and Respiratory SpR with an interest in pulmonary vascular disease, transplantation and interstitial lung disease

Manchester, England
Joined May 2017
Don't wanna be here? Send us removal request.
@Sheilaramjug
Sheila
2 years
RT @INSPIREresp_UK: WHAT’S YOUR BIG IDEA💡 🚨 We are open to expressions of interest for our next round of studies! 🚨 No research experie…
0
13
0
@Sheilaramjug
Sheila
2 years
RT @ActionPFsteve: BREAKING NEWS – NICE has approved antifibrotic drug nintedanib for ALL IPF patients. After 6-year campaign by @ActionPFC
0
149
0
@Sheilaramjug
Sheila
2 years
RT @RespTrainees: SWORD is the UK scheme for OLD & it needs more #respisbest clinicians. No OLD expertise required. Input cases = providing…
0
7
0
@Sheilaramjug
Sheila
2 years
RT @ILDIPFDoc_NI: Please share and raise awareness of lung fibrosis. Help get this song to number 1. Very honoured…
0
17
0
@Sheilaramjug
Sheila
2 years
RT @thelimbicrespUK: Watch Dr @Sheilaramjug talk about the importance of detecting pulmonary hypertension in patients with #ILD and the lat…
0
1
0
@Sheilaramjug
Sheila
2 years
RT @AlbertaPHdoc: Excited to see our review out in @TheLancet! We summarized the 2021 @CVCTForum on the evolution of #PulmonaryArterialHyp
0
25
0
@Sheilaramjug
Sheila
2 years
RT @zackferguson: 🚨BREAKING🚨 Thérèse Coffey has announced plans to overhaul emergency care. From October, A&Es must ensure that >90% of pat…
0
112
0
@Sheilaramjug
Sheila
2 years
RT @PilarRiveraOrt1: Wythenshawe Hospital/ Manchester Team 🇬🇧 in Barcelona 🇪🇸 #ERS2022 🫁 #teamwork @LPearmain @scstanel @Sheilaramjug @lizz
0
4
0
@Sheilaramjug
Sheila
2 years
RT @escardio: You cannot miss this one: check out the new 2022 #PulmonaryHypertension guidelines! #ESCCongress #ES
0
161
0
@Sheilaramjug
Sheila
2 years
RT @ATSBlueEditor: Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement 🔓 Open Access 🔗…
0
33
0
@Sheilaramjug
Sheila
2 years
RT @ProfJDChalmers: Join us! @ERSpublications Early Career Editor Mentoring Scheme is now open for applications. Become an associate editor…
0
19
0
@Sheilaramjug
Sheila
3 years
RT @INSPIREresp_UK: Can you contribute to research into use of PE thrombolysis across the UK? The ERUPT study will report outcomes and freq…
0
12
0
@Sheilaramjug
Sheila
3 years
RT @CritCultivation: Just a quick overview on bronchiectasis. Trying out dark theme background on this one. #FOAMed
Tweet media one
0
361
0
@Sheilaramjug
Sheila
3 years
RT @paul_mccallion: 1 week to go for our @TheACPRC “ABCs of ILD” course! A full morning packed with fantastic speakers - come and join us!!…
0
14
0
@Sheilaramjug
Sheila
3 years
RT @mmonrealriete: The risk of death after VTE was higher in smoking than in non-smoking patients, particularly in those initially presenti…
0
6
0
@Sheilaramjug
Sheila
3 years
RT @md_arianemacedo: Great review about Cancer Associated #VTE just released #naturereviews . Informative primeview that highlights prothro…
0
29
0
@Sheilaramjug
Sheila
3 years
RT @mmonrealriete: Full-dose or moderate-dose systemic thrombolysis in patients with acute PE? The #RIETEregistry experience, appearing so…
0
12
0
@Sheilaramjug
Sheila
3 years
RT @ERSpublications: Sarcoidosis-associated pulmonary hypertension is a significant cause of morbidity and mortality. A guide to screening,…
0
35
0
@Sheilaramjug
Sheila
3 years
RT @mmonrealriete: The risk of death after acute VTE was higher in smoking than in non-smoking patients, and in patients presenting with PE…
0
13
0